Breathe in, breathe out: New way of imaging lungs could improve COPD diagnosis, treatment

October 7, 2012
These PRM images of four different patients' lungs show how the scan technique can distinguish healthy lung areas (green) from those with early-stage damage (yellow) and emphysema (red). Credit: University of Michigan

A new approach to lung scanning could improve the diagnosis and treatment of a lung disease that affects approximately 24 million Americans and is the country's third-highest cause of death.

In a new paper published online in , a team from the University of Michigan Medical School reports on a technique called parametric response mapping, or PRM. They used PRM to analyze computed tomography, or CT, scans of the lungs of patients with , known as COPD, who took part in the national COPDGene study funded by the National Heart, and Blood Institute.

The researchers report that the PRM technique for analyzing CT scans allows them to better distinguish between early-stage damage to the small airways of the lungs, and more severe damage known as emphysema. They've also shown that the overall severity of a patient's disease, as measured with PRM, matches closely with the patient's performance on standard lung tests based on breathing ability.

"Essentially, with the PRM technique, we've been able to tell sub-types of COPD apart, distinguishing functional small airway disease or fSAD from emphysema and normal ," says Brian Ross, Ph.D., the Roger A. Berg Research Professor of radiology, professor of and senior author of the new paper. "We believe this offers a new path to more precise diagnosis and treatment planning, and a useful tool for precisely assessing the impact of new medications and other treatments."

COPD limits a patient's breathing ability, causing , coughing, wheezing and reduced ability to exercise, walk and do other things. Over time, many COPD patients become disabled as their disease worsens. Most often associated with smoking, COPD can also result from long-term exposure to dust, and certain gases and chemicals.

"In the last decade, techniques for imaging COPD have improved steadily, but PRM is the missing link – giving us a robust way to see small airway disease and personalize treatment," says Ella Kazerooni, M.D., M.S., FACS, a radiology professor who leads U-M's lung imaging program and is a member of the COPDGene trial.

Originally developed to show the response of brain tumors to treatment, the PRM technique allows researchers to identify COPD specific changes in three-dimensional lung regions over time.

Already, a U-M spinoff company, Imbio, has licensed U-M's patents on the PRM technique, and is developing the technology for use in early prediction of treatment response of brain tumors and other cancers. Now Imbio has begun developing PRM for COPD subtype diagnosis and tracking.

Ross and co-author Alnawaz Rehemtulla, Ph.D., the Ruth Tuttle Freeman Research Professor of Radiation Oncology, co-founded Imbio and act as scientific advisors to the company. They also co-direct the U-M Center for Molecular Imaging, which pursues a broad range of imaging research.

With the PRM technique, the researchers use powerful computer techniques to overlay the CT scan taken during a full inhalation with an image taken during a full exhalation. The overlaid, or registered, CT images share the same geometric space, so that the lung tissue in the inflated and deflated lungs aligns. The density of healthy lung tissue will change more between the two images than the density of diseased lung, allowing researchers to create a three-dimensional "map" of the patient's lungs.

PRM assign colors to each small 3-D area, called a voxel, according to the difference in signal changes within each of the areas between the two scans. Green means healthy, yellow means a reduced ability to push air out of the small sacs, and red means severely reduced ability.

PRM could take COPD sub-typing to the next level, say the authors of the new paper. "By distinguishing small airway abnormality from that involving the lung parenchyma, such as emphysema, PRM could help physicians personalize therapy for individual COPD patients – and select patients for clinical trials of new treatment options more precisely", says Fernando Martinez, M.D., M.S., an internal medicine professor who is also participated in the COPDGene trial.

"PRM can also help to track COPD progression or response to treatment over time," says lead author Craig Gabán, assistant professor of radiology. Although the current study mostly looked at a "snapshot" of CT scans taken a one time, it also includes data on two U-M COPD patients who were imaged over more than two years. More longitudinal data is needed to make sure that PRM works well for long-term tracking and studies are already underway.

While a simple breathing test called spirometry is still considered the best way to diagnose the disease, spirometry has limitations in its ability to distinguish between different types of lung damage that COPD patients experience.

"The PRM technique is a step forward in being able to better sub-classify with COPD so that targeted therapies can be developed," says co-author MeiLan Han, M.D. M.S., a U-M pulmonologist and COPDGene investigator. "This is one of many important studies that is being made possible by the data being collected through NHLBI funded COPD initiatives."

Explore further: Computed tomography shows changes in lungs associated with COPD flare-ups

More information: Nature Medicine, advance online publication, doi:10.1038/nm.2971

Related Stories

Computed tomography shows changes in lungs associated with COPD flare-ups

July 27, 2011
Using computed tomography (CT), researchers have identified two types of structural changes in the lungs of patients with chronic obstructive pulmonary disease (COPD) that are associated with frequent exacerbations, or episodes ...

Quantitative CT helps identify COPD patitients at risk for exacerbations

January 3, 2012
(Medical Xpress) -- National Jewish Health researchers and their colleagues in the COPDGene research consortium report that a computerized form of radiology, known as quantitative CT, can offer valuable prognostic information ...

Early COPD detection could help lung cancer diagnosis

November 16, 2011
Early screening of patients with chronic obstructive pulmonary disease (COPD) may help to detect lung cancer at an earlier stage, according to a new study.

Compound in broccoli sprouts cleans out diseased lungs: Experimental treatment for COPD in development

April 13, 2011
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients ...

Virtual lung models set to personalize asthma and COPD treatment

May 3, 2011
A team of international experts are set to develop a pioneering tool to help tailor the treatment of asthma and chronic obstructive pulmonary disease (COPD) as part of a new EU project.

Recommended for you

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

Compounds in desert creosote bush could treat giardia and 'brain-eating' amoeba infections

August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a ...

New malaria analysis method reveals disease severity in minutes

August 11, 2017
Left untreated, malaria can progress from being mild to severe—and potentially fatal—in 24 hours. So researchers at the University of British Columbia developed a method to quickly and sensitively assess the progression ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.